Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00818077 · ClinicalTrials.gov registry record

Using Continuous Glucose Monitoring to Understand the Glycemic Impact of Food

A clinical trial of Type 2 Diabetes and Currently Taking Metformin, sponsored by HealthPartners Institute.

Completed
Registry status
15
Enrollment target
1
Study location

NCT00818077: Completed study of Type 2 Diabetes and Currently Taking Metformin, sponsored by HealthPartners Institute.

NCT00818077 is a study of Type 2 Diabetes and Currently Taking Metformin that has completed, run by HealthPartners Institute. The registered enrollment target is 15 participants, below the 1,103-participant average among 288 other Type 2 Diabetes trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00818077, a study of Type 2 Diabetes and Currently Taking Metformin, has completed, sponsored by HealthPartners Institute.

COMPLETED
Registry status
15 participants
Enrollment target
1
Study location

Study Summary

This study will look at the impact that meals have on blood glucose (sugar) levels. Subjects will be asked to use a Continuous Glucose Monitoring System (CGM), which monitors glucose levels continuously. Breakfast and lunch meals will be provided and must be consumed at the International Diabetes Center.

Interventions

  • OTHER Continuous Glucose Monitoring of Carbohydrate Intake

Study Locations (1)

Minnesota

  • International Diabetes Center - Minneapolis

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2008-01
Est. Completion 2010-09

Sponsor

HealthPartners Institute

146 total trials

What the Registry Record Tells You About NCT00818077

The ClinicalTrials.gov registry entry for NCT00818077 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,103-participant average among 288 other Type 2 Diabetes trials with a reported enrollment target (99% lower). The listed sponsor is HealthPartners Institute, which has 146 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Type 2 Diabetes appearing as the primary indexed condition, and to 1 intervention - of which Continuous Glucose Monitoring of Carbohydrate Intake is the first listed.

NCT00818077 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT00818077 about?

NCT00818077 is a clinical study titled "Using Continuous Glucose Monitoring to Understand the Glycemic Impact of Food". This study will look at the impact that meals have on blood glucose (sugar) levels. Subjects will be asked to use a Continuous Glucose Monitoring System (CGM), which monitors glucose levels continuously. Breakfast and lunch meals will be provided and must be consumed at the International Diabetes Ce...

What is the current status of trial NCT00818077?

This trial is currently completed. The enrollment target is 15 participants. The study started on 2008-01. Estimated completion is 2010-09.

What conditions does trial NCT00818077 study?

This clinical trial studies the following conditions: Type 2 Diabetes, Currently Taking Metformin.

What interventions are being tested in trial NCT00818077?

The interventions under investigation include: Continuous Glucose Monitoring of Carbohydrate Intake (OTHER).

Who is sponsoring clinical trial NCT00818077?

This trial is sponsored by HealthPartners Institute, which has 146 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00818077 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Type 2 Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.